Literature DB >> 12378611

Versatile macrolide-responsive mammalian expression vectors for multiregulated multigene metabolic engineering.

Wilfried Weber1, René R Marty, Bettina Keller, Markus Rimann, Beat P Kramer, Martin Fussenegger.   

Abstract

The novel macrolide-inducible and -repressible mammalian gene regulation systems (E.REX) have been cloned into a variety of sophisticated expression configurations including (1) multi-purpose expression vectors, (2) pTRIDENT-based artificial operons, (3) dual-regulated expression strategies for independent control of two different transgenes, (4) autoregulated vectors for one-step installation of adjustable multigene expression, and (5) oncoretroviral and lentiviral plasmids for transduction of macrolide-, streptogramin- and tetracycline-dependent transactivators and production of cell lines supporting independent control of three different transgenes. This vector portfolio represents a construction kit-like toolbox for efficient installation of adjustable gene expression responsive to clinically licensed antibiotics and enables the design of multiregulated multigene metabolic engineering strategies required for biopharmaceutical manufacturing, gene therapy, and tissue engineering. Copyright 2002 Wiley Periodicals, Inc. Biotechnol Bioeng 80: 691-705, 2002.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378611     DOI: 10.1002/bit.10461

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

1.  Using cell engineering and omic tools for the improvement of cell culture processes.

Authors:  Darrin Kuystermans; Britta Krampe; Halina Swiderek; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2007-02-24       Impact factor: 2.058

2.  Advanced modular self-inactivating lentiviral expression vectors for multigene interventions in mammalian cells and in vivo transduction.

Authors:  Barbara Mitta; Markus Rimann; Markus U Ehrengruber; Martin Ehrbar; Valentin Djonov; Jens Kelm; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

3.  A synthetic low-frequency mammalian oscillator.

Authors:  Marcel Tigges; Nicolas Dénervaud; David Greber; Joerg Stelling; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2010-03-02       Impact factor: 16.971

4.  An engineered mammalian band-pass network.

Authors:  David Greber; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2010-08-06       Impact factor: 16.971

5.  Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice.

Authors:  Wilfried Weber; Ronald Schoenmakers; Manuela Spielmann; Marie Daoud El-Baba; Marc Folcher; Bettina Keller; Cornelia C Weber; Nils Link; Petra van de Wetering; Christoph Heinzen; Benoît Jolivet; Urs Séquin; Dominique Aubel; Charles J Thompson; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

6.  A novel mammalian expression system derived from components coordinating nicotine degradation in arthrobacter nicotinovorans pAO1.

Authors:  Laetitia Malphettes; Cornelia C Weber; Marie Daoud El-Baba; Ronald G Schoenmakers; Dominique Aubel; Wilfried Weber; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2005-07-07       Impact factor: 16.971

7.  Adeno-associated viral vectors engineered for macrolide-adjustable transgene expression in mammalian cells and mice.

Authors:  David A Fluri; Marie Daoud-El Baba; Martin Fussenegger
Journal:  BMC Biotechnol       Date:  2007-11-06       Impact factor: 2.563

8.  A gene expression system offering multiple levels of regulation: the Dual Drug Control (DDC) system.

Authors:  Marina Sudomoina; Ekaterina Latypova; Olga O Favorova; Erica A Golemis; Ilya G Serebriiskii
Journal:  BMC Biotechnol       Date:  2004-04-29       Impact factor: 2.563

9.  Intronically encoded siRNAs improve dynamic range of mammalian gene regulation systems and toggle switch.

Authors:  David Greber; Marie Daoud El-Baba; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2008-07-16       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.